LIPOPROTEINS DURING ORAL AND CUTANEOUS ADMINISTRATION OF OESTRADIOL-17-BETA TO MENOPAUSAL WOMEN

被引:52
作者
FAHRAEUS, L [1 ]
LARSSONCOHN, U [1 ]
WALLENTIN, L [1 ]
机构
[1] LINKOPING UNIV HOSP,DEPT INTERNAL MED,S-58185 LINKOPING,SWEDEN
来源
ACTA ENDOCRINOLOGICA | 1982年 / 101卷 / 04期
关键词
D O I
10.1530/acta.0.1010597
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:597 / 602
页数:6
相关论文
共 25 条
[21]   HDL3 AND HDL2 DETERMINATION BY A COMBINED ULTRA-CENTRIFUGATION AND PRECIPITATION PROCEDURE [J].
WALLENTIN, L ;
FAHRAEUS, L .
CLINICA CHIMICA ACTA, 1981, 116 (02) :199-208
[22]   METABOLIC AND HORMONAL EFFECTS OF POSTMENOPAUSAL ESTROGEN REPLACEMENT TREATMENT .2. PLASMA-LIPIDS [J].
WALLENTIN, L ;
LARSSONCOHN, U .
ACTA ENDOCRINOLOGICA, 1977, 86 (03) :597-607
[23]  
WHITEHEAD MI, 1980, PERCUTANEOUS ABSORPT, P231
[24]   CIRCULATING ESTRADIOL, ESTRONE AND GONADOTROPIN LEVELS FOLLOWING ADMINISTRATION OF ORALLY ACTIVE 17 BETA-ESTRADIOL IN POSTMENOPAUSAL WOMEN [J].
YEN, SSC ;
MARTIN, PL ;
BURNIER, AM ;
CZEKALA, NM ;
GREANEY, MO ;
CALLANTINE, MR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1975, 40 (03) :518-521
[25]  
1975, NIH DHEW75628 PUBL, V1